/Companies

Biolase

Irvine, US · Delaware corporation

Find your way into Biolase

Sign up to see every warm intro you have to Biolase

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biolase team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JRJohn R. Beaver
John R. BeaverExecutive
JT
Jonathan T. Lord, M.D.Named on SEC filing
EC
Elaine C. Wagner, D.D.S.Named on SEC filing
GS
Garrett SatoNamed on SEC filing
JR
Jess RoperNamed on SEC filing
TA
Todd A. NorbeNamed on SEC filing
RB
Richard B. Lanman, M.D.Named on SEC filing

Reported raises · per SEC filings

Form D private placements

$13.6M disclosed across 3 rounds · 2019–2023

▶$2.7MraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John R. BeaverExecutive Officer, Director
  • Jonathan LordDirector
  • Kathleen T. O'LoughlinDirector
  • Kenneth P. YaleDirector
  • Jess RoperDirector
  • Jennifer BrightExecutive Officer
  • Martha SomermanDirector
  • Carol Gomez SummerhaysDirector
Offering amount
$2.7M
Amount sold
$2.7M
Sales commissions
$96K
Placement agents
Maxim Group LLC
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.9MraisedJun 2020 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard B. LanmanDirector
  • Jess RoperDirector
  • Elaine C. WagnerDirector
  • Michael DiTollaDirector
  • Garrett SatoDirector
  • John R. BeaverExecutive Officer
  • Jonathan T. LordDirector
  • Todd A. NorbeExecutive Officer, Director
Offering amount
$6.9M
Amount sold
$6.9M
Sales commissions
$483.8K
Placement agents
The Benchmark Company LLC, Colliers Securities LLC
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedNov 2019 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan T. Lord, M.D.Director
  • Elaine C. Wagner, D.D.S.Director
  • Garrett SatoDirector
  • Jess RoperDirector
  • Todd A. NorbeExecutive Officer, Director
  • John R. BeaverExecutive Officer
  • Richard B. Lanman, M.D.Director
Offering amount
$4M
Amount sold
$4M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Biolase raised?
Biolase has disclosed $13.6M raised across 3 rounds.
Where is Biolase headquartered?
Biolase is headquartered in Irvine, US.